Literature DB >> 31309700

Comparison of three frailty models and a sarcopenia model in elderly patients with chronic obstructive pulmonary disease.

Kuniaki Hirai1, Akihiko Tanaka1, Tetsuya Homma1, Keisuke Kaneko1, Tomoki Uno1, Haruna Sato1, Ryo Manabe1, Shin Ohta1, Sojiro Kusumoto1, Fumihiro Yamaguchi1, Shintaro Suzuki1, Hironori Sagara1.   

Abstract

AIM: Frailty and sarcopenia affect the prognosis and quality of life of patients with chronic obstructive pulmonary disease (COPD). However, it remains uncertain which model is the most suitable for evaluating vulnerability in patients with COPD. We evaluated the validity of three frailty models - the Kihon Checklist (KCL), the Japanese version of the Cardiovascular Health Study and the Study of Osteoporotic Fractures - and one sarcopenia model for older patients with COPD.
METHODS: This cross-sectional study included 201 older (aged ≥65 years) outpatients with COPD. We used three frailty models and one sarcopenia model to identify their correlation with various indices that can evaluate the status of COPD and determine the most ideal model for evaluating vulnerability in patients with COPD.
RESULTS: The highest prevalence of frailty (38%) and lowest prevalence of robustness (26%) were observed using the KCL. Although all models reflected the characteristics of COPD, the KCL yielded the strongest correlations with clinically important physical, psychological and prognostic indices. The KCL yielded statistically significant differences in almost all indices among the three intergroup comparisons (robust, pre-frailty and frailty). The KCL was superior in extracting mood disorders to the other models.
CONCLUSION: Although all investigated models were useful, the KCL was the most suitable for evaluating the frailty status and might enable interventions in patients with COPD. Geriatr Gerontol Int 2019; 19: 896-901.
© 2019 Japan Geriatrics Society.

Entities:  

Keywords:  Kihon Checklist; chronic obstructive pulmonary disease; elderly; frailty; sarcopenia

Mesh:

Year:  2019        PMID: 31309700     DOI: 10.1111/ggi.13740

Source DB:  PubMed          Journal:  Geriatr Gerontol Int        ISSN: 1447-0594            Impact factor:   2.730


  6 in total

1.  Frailty in COPD: an analysis of prevalence and clinical impact using UK Biobank.

Authors:  Peter Hanlon; James Lewsey; Jennifer K Quint; Bhautesh D Jani; Barbara I Nicholl; David A McAllister; Frances S Mair
Journal:  BMJ Open Respir Res       Date:  2022-07

2.  Skeletal Muscle Composition Predicts Outcome in Critically Ill Patients.

Authors:  Sven H Loosen; Maximilian Schulze-Hagen; Tobias Püngel; Lukas Bündgens; Theresa Wirtz; Jakob N Kather; Mihael Vucur; Pia Paffenholz; Münevver Demir; Philipp Bruners; Christiane Kuhl; Christian Trautwein; Frank Tacke; Tom Luedde; Alexander Koch; Christoph Roderburg
Journal:  Crit Care Explor       Date:  2020-08-05

3.  Four different frailty models predict health outcomes in older patients with stable chronic obstructive pulmonary disease.

Authors:  Dai Zhang; Wen Tang; Li-Yang Dou; Jia Luo; Ying Sun
Journal:  BMC Geriatr       Date:  2022-01-16       Impact factor: 3.921

4.  Frailty and chronic respiratory disease: the need for a multidisciplinary care model.

Authors:  Emmanouil K Symvoulakis; Apostolos Kamekis; Elena Drakonaki; Semeli Mastrodemou; Christopher J Ryerson; Katerina Antoniou
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2021-09-30       Impact factor: 0.670

5.  A New Dyspnea Evaluation System Focusing on Patients' Perceptions of Dyspnea and Their Living Disabilities: The Linkage between COPD and Frailty.

Authors:  Keiji Oishi; Kazuto Matsunaga; Misa Harada; Junki Suizu; Keita Murakawa; Ayumi Chikumoto; Yuichi Ohteru; Kazuki Matsuda; Sho Uehara; Kazuki Hamada; Shuichiro Ohata; Yoriyuki Murata; Yoshikazu Yamaji; Maki Asami-Noyama; Nobutaka Edakuni; Tomoyuki Kakugawa; Tsunahiko Hirano
Journal:  J Clin Med       Date:  2020-11-06       Impact factor: 4.241

6.  Safety and Efficacy of Nontuberculous Mycobacteria Treatment among Elderly Patients.

Authors:  Yoshitaka Uchida; Jiro Terada; Tetsuya Homma; Hatsuko Mikuni; Kuniaki Hirai; Haruhisa Saito; Ryoichi Honda; Hironori Sagara
Journal:  Medicina (Kaunas)       Date:  2020-10-02       Impact factor: 2.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.